Literature DB >> 24091926

Severe congenital neutropenia and chronic neutrophilic leukemia: an intriguing molecular connection unveiled by oncogenic mutations in CSF3R.

Ivo P Touw1, Renée Beekman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24091926      PMCID： PMC3789450          DOI： 10.3324/haematol.2013.090571

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  30 in total

1.  Chronic neutrophilic leukaemia: 14 new cases of an uncommon myeloproliferative disease.

Authors:  J Böhm; H E Schaefer
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

2.  Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia.

Authors:  J M Hernández; M C del Cañizo; A Cuneo; J L García; N C Gutiérrez; M González; G Castoldi; J F San Miguel
Journal:  Ann Oncol       Date:  2000-04       Impact factor: 32.976

3.  Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia.

Authors:  F Dong; D C Dale; M A Bonilla; M Freedman; A Fasth; H J Neijens; J Palmblad; G L Briars; G Carlsson; A J Veerman; K Welte; B Löwenberg; I P Touw
Journal:  Leukemia       Date:  1997-01       Impact factor: 11.528

4.  Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.

Authors:  F Dong; R K Brynes; N Tidow; K Welte; B Löwenberg; I P Touw
Journal:  N Engl J Med       Date:  1995-08-24       Impact factor: 91.245

5.  A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.

Authors:  D C Dale; M A Bonilla; M W Davis; A M Nakanishi; W P Hammond; J Kurtzberg; W Wang; A Jakubowski; E Winton; P Lalezari
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

6.  An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia.

Authors:  Louisa V Forbes; Rosemary E Gale; Arnold Pizzey; Karin Pouwels; Amit Nathwani; David C Linch
Journal:  Oncogene       Date:  2002-09-05       Impact factor: 9.867

7.  CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.

Authors:  A Pardanani; T L Lasho; R R Laborde; M Elliott; C A Hanson; R A Knudson; R P Ketterling; J E Maxson; J W Tyner; A Tefferi
Journal:  Leukemia       Date:  2013-04-22       Impact factor: 11.528

8.  Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.

Authors:  M L McLemore; J Poursine-Laurent; D C Link
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

Review 9.  Haematological differences between chronic granulocytic leukaemia, atypical chronic myeloid leukaemia, and chronic myelomonocytic leukaemia.

Authors:  D A Galton
Journal:  Leuk Lymphoma       Date:  1992-08

10.  Perturbed granulopoiesis in mice with a targeted mutation in the granulocyte colony-stimulating factor receptor gene associated with severe chronic neutropenia.

Authors:  M H Hermans; A C Ward; C Antonissen; A Karis; B Löwenberg; I P Touw
Journal:  Blood       Date:  1998-07-01       Impact factor: 22.113
View more
  14 in total

1.  Secondary CNL after SAA reveals insights in leukemic transformation of bone marrow failure syndromes.

Authors:  Laurent Schmied; Patricia A Olofsen; Pontus Lundberg; Alexandar Tzankov; Martina Kleber; Jörg Halter; Mario Uhr; Peter J M Valk; Ivo P Touw; Jakob Passweg; Beatrice Drexler
Journal:  Blood Adv       Date:  2020-11-10

2.  SWATH-Proteomics of Ibrutinib's Action in Myeloid Leukemia Initiating Mutated G-CSFR Signaling.

Authors:  Pankaj Dwivedi; Somchai Chutipongtanate; David E Muench; Mohammad Azam; Harry Leighton Grimes; Kenneth D Greis
Journal:  Proteomics Clin Appl       Date:  2020-05-25       Impact factor: 3.494

Review 3.  Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies.

Authors:  Pankaj Dwivedi; Kenneth D Greis
Journal:  Exp Hematol       Date:  2016-10-24       Impact factor: 3.084

4.  Enhanced MAPK signaling is essential for CSF3R-induced leukemia.

Authors:  S Rohrabaugh; M Kesarwani; Z Kincaid; E Huber; J Leddonne; Z Siddiqui; Y Khalifa; K Komurov; H L Grimes; M Azam
Journal:  Leukemia       Date:  2016-12-27       Impact factor: 11.528

Review 5.  Identification of novel MECOM gene fusion and personalized therapeutic targets through integrative clinical sequencing in secondary acute myeloid leukemia in a patient with severe congenital neutropenia: a case report and literature review.

Authors:  James A Connelly; Rajen J Mody; Yi-Mi Wu; Dan R Robinson; Robert J Lonigro; Pankaj Vats; Erica Rabban; Bailey Anderson; Kelly Walkovich
Journal:  Cold Spring Harb Mol Case Stud       Date:  2018-04-02

6.  Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.

Authors:  Yuan Ouyang; Chun Qiao; Yu Chen; Su-Jiang Zhang
Journal:  Oncotarget       Date:  2017-03-28

Review 7.  Translating the Game: Ribosomes as Active Players.

Authors:  Piera Calamita; Guido Gatti; Annarita Miluzio; Alessandra Scagliola; Stefano Biffo
Journal:  Front Genet       Date:  2018-11-15       Impact factor: 4.599

8.  Mutation, drift and selection in single-driver hematologic malignancy: Example of secondary myelodysplastic syndrome following treatment of inherited neutropenia.

Authors:  Tomasz Wojdyla; Hrishikesh Mehta; Taly Glaubach; Roberto Bertolusso; Marta Iwanaszko; Rosemary Braun; Seth J Corey; Marek Kimmel
Journal:  PLoS Comput Biol       Date:  2019-01-07       Impact factor: 4.475

9.  Phospho serine and threonine analysis of normal and mutated granulocyte colony stimulating factor receptors.

Authors:  Pankaj Dwivedi; David E Muench; Michael Wagner; Mohammad Azam; H Leighton Grimes; Kenneth D Greis
Journal:  Sci Data       Date:  2019-04-09       Impact factor: 6.444

Review 10.  Granulocyte colony-stimulating factor receptor mutations in myeloid malignancy.

Authors:  Clifford Liongue; Alister Curtis Ward
Journal:  Front Oncol       Date:  2014-05-01       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.